XBP

XBP is not a normal operating company you can underwrite — it is the product of a July 29, 2025 'Business Combination' in which XBP Europe absorbed BPA, ETI's Americas/Asia operations, for a consideration of $1.00 precisely because BPA was 'encumbered' and sitting in Chapter 11. BPA filed on March 3, 2025 and only emerged on July 29, 2025, at which point it applied ASC 852 fresh-start accounting and the deal was booked as a reverse acquisition where the surviving public entity is treated as the *acquired* company. The practical consequence: the FY2024/FY2025 figures blend predecessor, fresh-start and reverse-merger bases, and they don't reconcile — a reported diluted EPS of $0.41 (the source of the flattering 5.8x P/E) sits alongside net income of -$215M and operating income of -$105M. When the headline valuation multiple is arithmetically incompatible with the loss statement, the multiple is noise, not a signal.

The fundamentals that are internally consistent are uniformly bad. Net income has been negative every year on record and deteriorated from -$13.1M (FY2023) to -$215M (FY2024); operating margin is -12.1%, net margin -24.7%, ROE -49.2%. Gross margin of 21.6% is thin for a services/tech workflow business, leaving little cushion. Most damning is liquidity: $11.7M of cash against $388M long-term debt plus $34.3M current debt, and negative working capital — $192M current assets versus $248M current liabilities. A company one restructuring removed from bankruptcy, carrying a -$351M accumulated deficit and 1.56x liabilities/equity, with barely two weeks of the reported D&A in cash, has no margin for a stumble.